The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 21, 2022

Filed:

Nov. 25, 2019
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Hisataka Kobayashi, Laurel, MD (US);

Peter Choyke, Rockville, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/704 (2006.01); A61K 39/395 (2006.01); A61K 41/00 (2020.01); A61K 49/16 (2006.01); A61K 47/68 (2017.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 16/32 (2006.01); A61K 45/06 (2006.01); G01N 33/50 (2006.01); A61K 49/00 (2006.01); A44C 15/00 (2006.01); A41D 13/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 31/704 (2013.01); A61K 41/0071 (2013.01); A61K 47/6803 (2017.08); A61K 47/6869 (2017.08); A61K 49/0032 (2013.01); A61K 49/0058 (2013.01); C07K 16/2863 (2013.01); C07K 16/30 (2013.01); C07K 16/3069 (2013.01); C07K 16/32 (2013.01); G01N 33/5011 (2013.01); A41D 13/0002 (2013.01); A41D 2400/32 (2013.01); A44C 15/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/73 (2013.01); C07K 2317/77 (2013.01);
Abstract

The present disclosure relates to compositions and methods of killing cells. In particular examples, the method includes contacting a cell having a cell surface protein with a therapeutically effective amount of an antibody-IR700 molecule, wherein the antibody specifically binds to the cell surface protein, such as a tumor-specific antigen on the surface of a tumor cell. The cell is subsequently irradiated, such as at a wavelength of 660 to 740 nm at a dose of at least 1 J cm. The cell is also contacted with one or more therapeutic agents (such as an anti-cancer agent), for example about 0 to 8 hours after irradiating the cell, thereby killing the cell. Also provided are methods of imaging cell killing in real time, using fluorescence lifetime imaging. Also provided are wearable devices that include an article of clothing, jewelry, or covering; and an NIR LED incorporated into the article, which can be used with the disclosed methods.


Find Patent Forward Citations

Loading…